Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Urología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
RENIS
H6D-MC-LVJJ: Estudio de fase 3, aleatorizado, doble ciego, controlado con placebo de tadalafilo para distrofia muscular de Duchenne.
INTERVENTIONAL
ID: IS000605
Completado
RENIS
Eficacia y seguridad de 3 dosis de S 38093 (2, 5 y 20 mg/día) frente a placebo, en co-administración con donepezilo (10 mg/día) en pacientes con Enfermedad de Alzheimer moderada Estudio internacional de fase IIb, de 24 semanas, multicéntrico, aleatorizado, doble ciego, controlado con placebo.
INTERVENTIONAL
ID: IS000376
Completado
RENIS
Estudio prospectivo para comparar la eficacia y seguridad de masitinib versus placebo en el tratamiento de pacientes con esclerosis lateral amiotrófica (ELA)
INTERVENTIONAL
ID: IS000340
Completado
RENIS
WN25203-Estudio multicéntrico, aleatorizado, doble ciego, controlado con placebo, de grupos paralelos, de dos años de duración, para evaluar el efecto de RO4909832 subcutáneo en la cognición y el funcionamiento en la enfermedad de Alzheimer Prodrómica con opción a dos años de tratamiento adicional.
INTERVENTIONAL
ID: IS000291
Activo, no recluta
RENIS
Estudio Observacional de Casos y Controles para Evaluar la Frecuencia de Crisis y los Eventos Adversos Producidos en Pacientes Medicados con Drogas Antiepilépticas Similares y Genéricas Vs Aquellos Medicados con Drogas Antiepilépticas Originales en un Hospital de la República Argentina
OBSERVATIONAL
ID: IS000150
Activo, no recluta
RENIS
ADNI II
OBSERVATIONAL
ID: IS000141
Suspendido
RENIS
DMD 114349
INTERVENTIONAL
ID: IS000093
Completado
RENIS
18F-Fdopa PET en Enfermedad de Parkinson
INTERVENTIONAL
ID: IS000085
Completado
RENIS
DMD114044
INTERVENTIONAL
ID: IS000075
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double Blind Phase III Study To Evaluate Adjuvant cG250 Treatment Versus Placebo In Patients With Clear Cell RCC And High Risk of Recurrence (ARISER)
INTERVENTIONAL
Inicio: 1 de jul de 2004
ID: NCT00087022
Activo, no recluta
Fase 3
ClinicalTrials.gov
ATLAS: A Randomized, Double-blind, Placebo-controlled Phase 3 Study of JNJ-56021927 in Subjects With High-risk, Localized or Locally Advanced Prostate Cancer Receiving Treatment With Primary Radiation Therapy
INTERVENTIONAL
Inicio: 19 de nov de 2015
ID: NCT02531516
Terminado
ClinicalTrials.gov
A NIS of Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial Cancer in Argentina and Brazil -LATAM AVENUE
OBSERVATIONAL
Inicio: 18 de ene de 2023
ID: NCT05568407
Completado
ClinicalTrials.gov
ARI103094-Follow-Up Study for REDUCE Study Subjects
OBSERVATIONAL
Inicio: 9 de abr de 2009
ID: NCT00883909
Completado
ClinicalTrials.gov
Development of Urinary-based Assay to Determine Treatment Coverage With Albendazole in Mass Drug Administration Programs
INTERVENTIONAL
Inicio: 17 de jul de 2019
ID: NCT04041427
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Multicenter, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Atezolizumab Given in Combination With Cabozantinib Versus Cabozantinib Alone in Patients With Inoperable, Locally Advanced, or Metastatic Renal Cell Carcinoma Who Experienced Radiographic Tumor Progression During or After Immune Checkpoint Inhibitor Treatment
INTERVENTIONAL
Inicio: 28 de jul de 2020
ID: NCT04338269
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Open-Label, Controlled, Multi-Center, Global Study of First-Line Durvalumab in Combination With Standard of Care Chemotherapy and Durvalumab in Combination With Tremelimumab and Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone in Patients With Unresectable Locally Advanced or Metastatic Urothelial Cancer.
INTERVENTIONAL
Inicio: 27 de sept de 2018
ID: NCT03682068
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Combinations of Solifenacin Succinate and Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in the Treatment of Overactive Bladder
INTERVENTIONAL
Inicio: 5 de nov de 2013
ID: NCT01972841
Completado
ClinicalTrials.gov
A Retrospective Medical Record Review of First-Line Sunitinib Administration Schedules and Outcomes Among Patients With Metastatic Renal Cell Carcinoma in Latin America
OBSERVATIONAL
Inicio: 13 de dic de 2019
ID: NCT04115189
Reclutando
ClinicalTrials.gov
The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling
OBSERVATIONAL
Inicio: 20 de dic de 2025
ID: NCT06717295
Completado
ClinicalTrials.gov
Effectiveness and Safety of Firmagon® in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in Argentina
OBSERVATIONAL
Inicio: 1 de mar de 2013
ID: NCT01861236
Anterior
1
...
8
9
10
...
434
Siguiente
Filtros